San Donato Hospital
| Italia | Turchia | Austria | |
| Tomoterapia | da $32,000 | da $12,000 | da $30,000 |
| Terapia ormonale | da $2,500 | da $399 | da $7,000 |
| Terapia di deprivazione androgenica | da $3,000 | da $1,500 | da $4,500 |
| Terapia con protoni | da $70,000 | da $70,000 | da $80,000 |
| Sistema robotico Da Vinci | da $18,000 | da $9,500 | da $22,000 |
Bookimed non aggiunge costi extra ai prezzi dei trattamenti di Tumore della prostata. Le tariffe provengono dai listini ufficiali delle cliniche. Pagherai direttamente in clinica al tuo arrivo nel paese.
Bookimed si impegna per la tua sicurezza. Lavoriamo solo con strutture che mantengono elevati standard internazionali nei trattamenti di Tumore della prostata e hanno le licenze necessarie per servire pazienti internazionali in tutto il mondo.
Bookimed offre assistenza esperta gratuita. Un coordinatore medico personale ti supporta prima, durante e dopo il trattamento, risolvendo qualsiasi problema. Non sarai mai solo nel tuo percorso di trattamento per Tumore della prostata.
Il medico è il capo del Dipartimento di Radioterapia presso l'Ospedale di Ricerca San Raffaele di Milano, posizione che ricopre dal 2008. Con un focus su metodi di ipofrazionamento ad alta precisione per i tumori della prostata, il medico è il coordinatore italiano del Gruppo Italiano di Brachiterapia dal 1999. In precedenza, il medico ha guidato l'Unità Funzionale di Tomoterapia e ha servito come oncologo radioterapico senior nello stesso ospedale.<\/p>
I successi educativi includono una laurea in medicina generale e chirurgia e una specializzazione in radioterapia oncologica presso l'Università di Milano. Il medico ha scritto 200 studi in oncologia radioterapica ed è membro di diverse società oncologiche prestigiose.<\/p>
Il medico è un esperto leader in urologia e andrologia, dirigendo l'Istituto di Ricerca Urologica in Italia. Specializzandosi in chirurgia minimamente invasiva e robotica, il medico ha eseguito oltre 8.000 interventi di urologia e andrologia e ha sviluppato un metodo unico per correggere la disfunzione venosa occlusiva.<\/p>
Laureato all'Università di Milano, il medico ha una specializzazione in urologia e una borsa di studio onoraria dal Royal College of Surgeons of England. Con oltre 1.000 articoli pubblicati, il medico è riconosciuto come uno dei ricercatori più influenti dell'ultimo decennio.<\/p>
Il medico ha ricevuto numerosi premi, tra cui il Premio Hugh Hampton Young e il Premio alla Carriera Frans Debruyne.<\/p>
Dr. Alessandro Calarco is a urologist at Ospedale San Carlo di Nancy in Rome. He holds an international patent for a flow reducer used in kidney stone surgery. Dr. Calarco specializes in minimally invasive and endourological procedures for complex conditions. He treats prostate cancer, kidney stones, and varicocele using surgical and reconstructive techniques.
Il medico è il Direttore dell'Unità di Oncologia Radioterapica e possiede una laurea in Medicina e Chirurgia presso l'Università La Sapienza, Roma, Italia, con una specializzazione in Oncologia Radioterapica presso l'Università Cattolica del Sacro Cuore, Roma, Italia.<\/p>
Specializzato in applicazioni ad alta tecnologia in Oncologia Radioterapica, il medico è esperto in Terapia Radiante a Modulazione di Intensità, Terapia Radiante Stereotassica, Terapia Radiante Adattativa e Brachiterapia. Il medico si concentra sull'ottimizzazione dei trattamenti radianti utilizzando immagini avanzate per la delineazione del volume bersaglio e integrando la radioterapia con chirurgia e chemioterapia, in particolare per i tumori del tratto gastrointestinale superiore, della prostata e del polmone.<\/p>
Il medico è Professore Associato in Oncologia Radioterapica presso l'Università Cattolica del Sacro Cuore ed è membro della facoltà del Corso di Insegnamento ESTRO.<\/p>
Italy offers elite prostate cancer care at IRCCS-accredited facilities like San Raffaele in Milan and Ospedale San Carlo di Nancy in Rome. These centers feature the da Vinci robotic system for nerve-sparing surgery. Leading specialists like Prof. Francesco Montorsi have performed over 8,000 specialized urological procedures.
Bookimed Expert Insight: While many search for general hospital rankings, our data suggests focusing on surgeon-specific caseloads within Milan's IRCCS-accredited cluster. San Raffaele stands out not just for volume, but for clinical research integration. Their specialists often serve as national coordinators for advanced protocols like brachytherapy, ensuring patients access treatment standards that regional centers may not yet offer.
Patient Consensus: Patients emphasize that accessing high-volume surgeons who perform over 200 annual prostatectomies is more critical than the hospital's general reputation. Many recommend bringing original pathology slides for a second opinion at major Milanese centers to ensure accurate staging before surgery.
Italy offers advanced medical technologies focusing on robotic surgery and precision oncology. Systems like Da Vinci enable minimally invasive prostatectomies with high success rates. Specialized centers also provide proton therapy and high-precision hypofraction methods. These institutions maintain international accreditations for complex oncology and urology care.
Bookimed Expert Insight: Data shows Italy's leading research hospitals achieve massive surgical volumes. San Raffaele in Milan performs over 52,000 operations annually. This high frequency allows surgeons like Dr. Francesco Montorsi to complete over 8,000 procedures. Patients benefit from this extreme specialization. It often leads to better preservation of urinary and sexual function compared to lower-volume centers.
Patient Consensus: Patients note that Italian centers offer high robotic expertise with faster scheduling than other European destinations. They emphasize confirming the surgeon performs over 300 robotic cases annually to ensure the best functional outcomes.
Average waiting times for prostate cancer treatment in Italy range from 30 to 93 days depending on clinical urgency. The Italian National Healthcare System (SSN) prioritizes urgent cases within 72 hours. Non-urgent oncological surgeries typically proceed within approximately 29 to 35 days.
Bookimed Expert Insight: High-volume research centers like San Raffaele in Milan manage over 52,000 operations annually. Patients can significantly reduce wait times by accessing these accredited facilities through private or Libera professione channels. This approach bypasses standard public queues while maintaining access to top researchers like Prof. Dr. Francesco Montorsi.
Patient Consensus: Patients note that requesting a specific urgency code from their urologist is vital for faster scheduling. Many suggest using online regional tracking systems to monitor and appeal potential treatment delays.
Patients should prioritize questions about specific Gleason scores and the surgeon's personal robotic prostatectomy volume. Inquire about multidisciplinary tumor boards at facilities like San Raffaele. Clarify if treatments like da Vinci robotic surgery or proton-beam therapy fit your specific cancer stage and grade.
Bookimed Expert Insight: Italian centers of excellence like San Raffaele and San Carlo di Nancy often combine clinical care with intensive research. High-volume specialists like Dr. Francesco Montorsi have performed over 8,000 surgeries. This level of expertise often leads to better preservation of nerve function and faster recovery. Always ask if your case will be reviewed by a multidisciplinary equipe including radiation oncologists.
Patient Consensus: Patients note it is essential to bring a printed PSA history and biopsy report. They emphasize asking for a written staging summary to avoid confusion during follow-up care.
Prostate cancer treatments in Italy typically involve surgery, radiotherapy, or hormone therapy. Common side effects include urinary incontinence, erectile dysfunction, bowel changes, and fatigue. Clinics in Milan and Rome use robotic systems and high-precision radiation to reduce these impacts.
Bookimed Expert Insight: Italian centres of excellence show a strong trend toward volume-based safety. San Raffaele in Milan performs over 52,000 operations annually. Prof. Dr Francesco Montorsi there has personally handled over 8,000 urology cases. High surgical volume often leads to better nerve-sparing outcomes. This is vital for preserving sexual function after a prostatectomy.
Patient Consensus: Patients in Italy note that side effects vary greatly by treatment. They suggest planning early for urinary aids. They also recommend discussing sexual rehabilitation before starting any hormone or radiation cycles.
Italy offers Australian patients access to high-volume IRCCS-accredited research hospitals. These centres specialise in robotic prostatectomy and radiotherapy. Leading clinics in Milan and Rome use the Da Vinci robotic system. They also use PSMA PET/CT imaging for precise prostate cancer staging and treatment.
Bookimed Expert Insight: Italian urology stands out because top specialists often work as both researchers and surgeons. Prof. Francesco Montorsi at San Raffaele has published over 1,000 papers. He leads a department that handles 300,000 patients annually. This massive case volume means these teams manage complex cases that smaller centres rarely see.
Patient Consensus: Patients travel to Italy to confirm treatment plans through multidisciplinary teams. They often seek second opinions for complex pathology reviews. Many suggest comparing a clinic's specific prostate cancer case volume when choosing a robotic surgeon.
Italy offers prostate cancer treatments including robotic surgery, high-precision radiotherapy, and targeted nuclear medicine. Centres in Milan and Rome use Da Vinci systems for nerve-sparing prostatectomies. Patients also access specialised techniques like Tomotherapy and PSMA-targeted therapies at JCI-accredited facilities.
Bookimed Expert Insight: Italian urology excellence is concentrated in Milan research hospitals like San Raffaele. This facility alone performs over 52,000 operations annually. Prof. Francesco Montorsi has authored over 1,000 papers. This shows academic depth rarely seen outside major US teaching hospitals.
Patient Consensus: Patients note it is important to focus on recovery timelines and local logistics. They suggest prioritising clinics that offer integrated diagnostic staging like PSMA PET-CT.
Italy offers active clinical trials for advanced prostate cancer. Research centres in Milan and Rome focus on targeted agents, radioligand therapy, and combination treatments. Italian institutions participate in international phase 3 studies for metastatic cases. Patients find options for PARP inhibitors and immunotherapy protocols through major research hospitals.
Bookimed Expert Insight: Italy's IRCCS-accredited centres like San Raffaele and San Donato have official recognition for research-led care. This status allows these clinics to provide faster access to experimental protocols for metastatic cases. Professor Francesco Montorsi at San Raffaele has performed over 8,000 surgeries. This high-volume surgical perspective often informs these clinical trial designs.